Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3268-3278

  Ogunniyi, Abiodun D ^a   Mahdi, Layla K ^a   Trappetti, Claudia ^a   Verhoeven, Nadine ^a   Mermans, Daphne ^a   Van der Hoek, Mark B ^a   Plumptre, Charles D ^a   Paton, James C ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; PNEUMOCOCCUS VACCINE; TRANSCRIPTOME;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BLOOD; FEMALE; GENE IDENTIFICATION; HAEMOPHILUS INFLUENZAE TYPE B; LUNG; MOUSE; NASOPHARYNX; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; SITE DIRECTED MUTAGENESIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; UPREGULATION; WILD TYPE;

EID: 84867600073     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00295-12     Document Type: Article

References (51)

1. Abbott DW, et al. 2010. The molecular basis of glycogen breakdown and transport in Streptococcus pneumoniae. Mol. Microbiol. 77:183-199.
2. Alexander JE, et al. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
3. Barocchi MA, Censini S, Rappuoli R. 2007. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine 25:2963-2973.
4. Bartilson M, et al. 2001. Differential fluorescence induction reveals Streptococcus pneumoniae loci regulated by competence stimulatory peptide. Mol. Microbiol. 39:126-135.
5. Berry AM, Paton JC. 2000. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect. Immun. 68:133-140.
6. Briles DE, Novak L, Hotomi M, van Ginkel FW, King J. 2005. Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect. Immun. 73:6945-6951.
7. Brown JS, Gilliland SM, Holden DW. 2001. A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence. Mol. Microbiol. 40:572-585.
8. Brown JS, Ogunniyi AD, Woodrow MC, Holden DW, Paton JC. 2001. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect. Immun. 69:6702-6706.
9. Cognet I, et al. 2003. Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation. J. Immunol. Methods 272:199-210.
10. Giefing C, et al. 2008. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205:117-131.
11. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. 2011. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect. Immun. 79:4122-4130.
12. Hava DL, Camilli A. 2002. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol. Microbiol. 45:1389-1406.
13. Hava DL, LeMieux J, Camilli A. 2003. From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol. Microbiol. 50: 1103-1110.
14. Horton RM, et al. 1993. Gene splicing by overlap extension. Methods Enzymol. 217:270-279.
15. Hoskins J, et al. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 183:5709-5717.
16. Jomaa M, et al. 2005. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae. Infect. Immun. 73:6852-6859.
17. Kerr AR, et al. 2004. The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect. Immun. 72:3902-3906.
18. Lau GW, et al. 2001. A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol. Microbiol. 40:555-571.
19. LeMessurier KS, Ogunniyi AD, Paton JC. 2006. Differential expression of key pneumococcal virulence genes in vivo. Microbiology 152:305-311.
20. Lipsitch M, et al. 2000. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine 18:2895-2901.
21. -ΔΔCT method. Methods 25: 402-408.
22. Mahdi LK, Ogunniyi AD, LeMessurier KS, Paton JC. 2008. Pneumococcal virulence gene expression and host cytokine profiles during pathogenesis of invasive disease. Infect. Immun. 76:646-657.
23. Marra A, et al. 2002. Differential fluorescence induction analysis of Streptococcus pneumoniae identifies genes involved in pathogenesis. Infect. Immun. 70:1422-1433.
24. McAllister LJ, Ogunniyi AD, Stroeher UH, Leach AJ, Paton JC. 2011. Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates. Infect. Immun. 79:4839-4849.
25. McCluskey J, Hinds J, Husain S, Witney A, Mitchell TJ. 2004. A two-component system that controls the expression of pneumococcal surface antigen A (PsaA) and regulates virulence and resistance to oxidative stress in Streptococcus pneumoniae. Mol. Microbiol. 51:1661-1675.
26. Meinke A, Henics T, Hanner M, Minh DB, Nagy E. 2005. Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 23:2035-2041.
27. Meng JP, et al. 2008. Identification of Streptococcus pneumoniae genes specifically induced in mouse lung tissues. Can. J. Microbiol. 54:58-65.
28. Moffitt KL, et al. 2011. TH17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9:158-165.
29. Molzen TE, et al. 2011. Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect. Immun. 79:288-297.
30. O'Brien KL, et al. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902.
31. Oggioni MR, et al. 2006. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol. Microbiol. 61:1196-1210.
32. Ogunniyi AD, Folland RL, Briles DE, Hollingshead SK, Paton JC. 2000. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect. Immun. 68:3028-3033.
33. Ogunniyi AD, Giammarinaro P, Paton JC. 2002. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 148: 2045-2053.
34. Ogunniyi AD, Grabowicz M, Briles DE, Cook J, Paton JC. 2007. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75:350-357.
35. 2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J. 23:731-738.
36. Ogunniyi AD, et al. 2010. Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. J. Bacteriol. 192:4489-4497.
37. Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC. 2001. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69:5997-6003.
38. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. 2004. Tissuespecific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190:1661-1669.
39. Orihuela CJ, et al. 2003. Organ-specific models of Streptococcus pneumoniae disease. Scand. J. Infect. Dis. 35:647-652.
40. Orihuela CJ, et al. 2004. Microarray analysis of pneumococcal gene expression during invasive disease. Infect. Immun. 72:5582-5596.
41. Paton JC. 2004. New pneumococcal vaccines: basic science developments, p 382-402. In Tuomanen EI, Mitchell TJ, Morrison DA, Spratt BG (ed), The pneumococcus. ASM Press, Washington, DC.
42. Paton JC, Boslego JW. 2008. Protein vaccines, p 421-436. In Siber GR, Klugman KP, Makela PH (ed), Pneumococcal vaccines: the impact of conjugate vaccines. ASM Press, Washington, DC.
43. Paton JC, et al. 1991. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect. Immun. 59:2297-2304.
44. Polissi A, et al. 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66:5620-5629.
45. Rappuoli R. 2000. Reverse vaccinology. Curr. Opin. Microbiol. 3:445-450.
46. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
47. Smyth GK. 2005. Limma: linear models for microarray data, p 397-420. In Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (ed), Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
48. Smyth GK, Speed T. 2003. Normalization of cDNA microarray data. Methods 31:265-273.
49. Tettelin H, et al. 2001. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293:498-506.
50. Weiser JN, Austrian R, Sreenivasan PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
51. Whalan RH, et al. 2005. PiuA and PiaA, iron uptake lipoproteins of Streptococcus pneumoniae, elicit serotype independent antibody responses following human pneumococcal septicaemia. FEMS Immunol. Med. Microbiol. 43:73-80.